Last updated
T-Therapeutics: Capital Raising
T-Therapeutics closed a $133m Series B to advance T-cell medicines toward the clinic.
Source: Cambridge Independent: Business
- Who
- T-Therapeutics · UK
- What happened
- T-Therapeutics closed a $133m Series B to advance T-cell medicines toward the clinic.
- When
- 2026-11-12
- So what
- T-Therapeutics's raise resets the leadership agenda more than the balance sheet.
The leadership read
T-Therapeutics's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across EMEA.
Market context: MitchelLake's Talent Market Index sits at 97.6 (Neutral), down 3.4 on the prior month; EMEA hiring signal is running rising (+5.9pts).
T-Therapeutics: 1 signal in the last 90 days.
MitchelLake in this thematic
More signals across EMEA
Capital Raising · EMEA
Harwood Private Capital →Harwood Private Capital received an additional £40m commitment from the British Business Bank, supporting the first close of Harwood Private Capital UK Fund II and bringing total committed capital to about £120m.
Capital Raising · EMEA
Nebuly →Turin-based Nebuly raised a $21m Series A led by Planven, with Exor Ventures, Tenacity Capital, TGVG Capital, Fastweb+Vodafone and CDP Venture Capital participating; it helps businesses measure financial return from AI agents.
Capital Raising · EMEA
AICertified →Irish AI training firm AICertified aims to raise up to €5m over the next year and operates in 15 countries, seeking to at least double that footprint.
Capital Raising · EMEA
EbonyLife Group →EbonyLife Group and Logical African Partners, the African investment vehicle of France's Logical Pictures, launched a $50 million Afro Film Fund to finance about 35 African films over eight years.
Capital Raising · EMEA
Zilch Technology →London-based Zilch expanded its debt facilities by £165m to a total of £395m, led by Deutsche Bank with participation from two large credit funds, to support lending of up to £6bn annually and its Pay Monthly product. Reports say it is preparing a potential £1.5bn London IPO.
Capital Raising · EMEA
Rem3dy Health →Birmingham-based Rem3dy Health received an undisclosed strategic investment from Hikma Ventures, the corporate venture arm of Hikma Pharmaceuticals, alongside an exclusive commercial partnership. Revenue grew 61% to £10.2m.
Where this lands in our work
- Executive Search →
Capital raised becomes leadership hired — the executive build follows the announcement.
- Scale-up →
Each doubling of the team forces a new leadership layer — the graduation pattern.
- Executive Search: EMEA →
Our EMEA practice runs the searches behind signals like this one.
Intelligence powered by Autonodal ↗
Nearby in the record